These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34248994)

  • 1. Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.
    Zhu KJ; Yang PD; Xu Q
    Front Immunol; 2021; 12():695768. PubMed ID: 34248994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Morbihan disease treated with tofacitinib successfully.
    Li ZY; Chi CC; Cai SQ
    Front Immunol; 2023; 14():1177316. PubMed ID: 37342330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two case reports of tofacitinib topical treatment: A game-changer in the management of vasculitis ulcer?
    Haridas V; Hoskatti C; Choukimath SM; Haridas K; Patil P; Pavan KJ; Shetty P
    Int J Rheum Dis; 2024 Aug; 27(8):e15283. PubMed ID: 39078086
    [No Abstract]   [Full Text] [Related]  

  • 4. Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
    van der Heijde D; Strand V; Tanaka Y; Keystone E; Kremer J; Zerbini CAF; Cardiel MH; Cohen S; Nash P; Song YW; Tegzová D; Gruben D; Wallenstein G; Connell CA; Fleischmann R;
    Arthritis Rheumatol; 2019 Jun; 71(6):878-891. PubMed ID: 30666826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies.
    Burgos-Vargas R; Cardiel M; Xibillé D; Pacheco-Tena C; Pascual-Ramos V; Abud-Mendoza C; Mahgoub E; Rahman M; Fan H; Rojo R; García E; Santana K
    Reumatol Clin (Engl Ed); 2019; 15(1):43-53. PubMed ID: 28552437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature review.
    Yu Z; Wang L; Quan M; Zhang T; Song H
    Rheumatology (Oxford); 2021 Apr; 60(4):1700-1707. PubMed ID: 33024992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous leukocytoclastic vasculitis and myelodysplastic syndrome with little or no evidence of associated autoimmune disorders-a case report and a brief review of the literature.
    DAS M; Chhabra R; Hinton SW
    Am J Med Sci; 2008 Oct; 336(4):368-71. PubMed ID: 18854686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies.
    Radominski SC; Cardiel MH; Citera G; Goecke A; Jaller JJ; Lomonte ABV; Miranda P; Velez P; Xibillé D; Kwok K; Rojo R; García EG
    Reumatol Clin; 2017; 13(4):201-209. PubMed ID: 27317492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate.
    Fleischmann R
    Expert Opin Pharmacother; 2017 Oct; 18(14):1525-1533. PubMed ID: 28829236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous leukocytoclastic vasculitis with cervical tuberculous lymphadenitis: a case report and literature review.
    Kim HM; Park YB; Maeng HY; Lee SK
    Rheumatol Int; 2006 Oct; 26(12):1154-7. PubMed ID: 16830160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.
    Moghadam-Kia S; Charlton D; Aggarwal R; Oddis CV
    Rheumatology (Oxford); 2019 Jun; 58(6):1011-1015. PubMed ID: 30608616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib for the treatment of refractory or glucocorticoid-dependent cutaneous leukocytoclastic vasculitis.
    Ma J; Lu W; Yan D; Liu Z; Xue L
    Dermatol Ther; 2022 Nov; 35(11):e15780. PubMed ID: 35988047
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
    Bokhari L; Sinclair R
    Int J Dermatol; 2018 Dec; 57(12):1464-1470. PubMed ID: 30160787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.
    Damsky W; Thakral D; McGeary MK; Leventhal J; Galan A; King B
    J Am Acad Dermatol; 2020 Mar; 82(3):612-621. PubMed ID: 31185230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
    Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K
    RMD Open; 2019; 5(1):e000742. PubMed ID: 30886732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis.
    Itoh I; Kasuno K; Yamamoto C; Takahashi N; Shimizu H; Ojima T; Hayashi S; Kimura H; Iwano M
    Intern Med; 2020 Mar; 59(6):817-821. PubMed ID: 31813912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature.
    Sánchez-Pérez J; Peñas PF; Ríos-Buceta L; Fernández-Herrera J; Fraga J; García-Díez A
    Dermatology; 1996; 193(3):230-5. PubMed ID: 8944346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tuberculosis presenting as cutaneous leucocytoclastic vasculitis.
    Verma A; Aggarwal S; Singh R; Mittal T
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37202110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.